179 related articles for article (PubMed ID: 12732183)
21. RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
Lee JW; van Wijnen A; Bae SC
Adv Exp Med Biol; 2017; 962():321-332. PubMed ID: 28299666
[TBL] [Abstract][Full Text] [Related]
22. Expression of galectin-3 in skeletal tissues is controlled by Runx2.
Stock M; Schäfer H; Stricker S; Gross G; Mundlos S; Otto F
J Biol Chem; 2003 May; 278(19):17360-7. PubMed ID: 12604608
[TBL] [Abstract][Full Text] [Related]
23. Identification and comparative analysis of a second runx3 promoter.
Rini D; Calabi F
Gene; 2001 Jul; 273(1):13-22. PubMed ID: 11483356
[TBL] [Abstract][Full Text] [Related]
24. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease.
Sato S; Kimura A; Ozdemir J; Asou Y; Miyazaki M; Jinno T; Ae K; Liu X; Osaki M; Takeuchi Y; Fukumoto S; Kawaguchi H; Haro H; Shinomiya K; Karsenty G; Takeda S
Arthritis Rheum; 2008 Sep; 58(9):2764-75. PubMed ID: 18759297
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
[TBL] [Abstract][Full Text] [Related]
26. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
[TBL] [Abstract][Full Text] [Related]
27. Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization.
Kim HR; Oh BC; Choi JK; Bae SC
J Cell Biochem; 2008 Nov; 105(4):1048-58. PubMed ID: 18767071
[TBL] [Abstract][Full Text] [Related]
28. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
[TBL] [Abstract][Full Text] [Related]
29. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.
Woolf E; Xiao C; Fainaru O; Lotem J; Rosen D; Negreanu V; Bernstein Y; Goldenberg D; Brenner O; Berke G; Levanon D; Groner Y
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7731-6. PubMed ID: 12796513
[TBL] [Abstract][Full Text] [Related]
30. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins.
Miyazono K; Maeda S; Imamura T
Oncogene; 2004 May; 23(24):4232-7. PubMed ID: 15156178
[TBL] [Abstract][Full Text] [Related]
31. Functional relationship between p53 and RUNX proteins.
Bae SC; Kolinjivadi AM; Ito Y
J Mol Cell Biol; 2019 Mar; 11(3):224-230. PubMed ID: 30535344
[TBL] [Abstract][Full Text] [Related]
32. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene.
Stewart M; Terry A; Hu M; O'Hara M; Blyth K; Baxter E; Cameron E; Onions DE; Neil JC
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8646-51. PubMed ID: 9238031
[TBL] [Abstract][Full Text] [Related]
33. Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development.
Smith N; Dong Y; Lian JB; Pratap J; Kingsley PD; van Wijnen AJ; Stein JL; Schwarz EM; O'Keefe RJ; Stein GS; Drissi MH
J Cell Physiol; 2005 Apr; 203(1):133-43. PubMed ID: 15389629
[TBL] [Abstract][Full Text] [Related]
34. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
35. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
[TBL] [Abstract][Full Text] [Related]
36. RUNX transcription factors as key targets of TGF-beta superfamily signaling.
Ito Y; Miyazono K
Curr Opin Genet Dev; 2003 Feb; 13(1):43-7. PubMed ID: 12573434
[TBL] [Abstract][Full Text] [Related]
37. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
Ito Y
Adv Cancer Res; 2008; 99():33-76. PubMed ID: 18037406
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
39. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
Lee KS; Hong SH; Bae SC
Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
[TBL] [Abstract][Full Text] [Related]
40. Smad-Runx interactions during chondrocyte maturation.
Leboy P; Grasso-Knight G; D'Angelo M; Volk SW; Lian JV; Drissi H; Stein GS; Adams SL
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S15-22. PubMed ID: 11263661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
